Compositional brain scores capture Alzheimer's disease-specific structural brain patterns along the disease continuum


Por: Genius, P, Calle, ML, Rodríguez-Fernández, B, Minguillon, C, Cacciaglia, R, Garrido-Martin, D, Esteller, M, Navarro, A, Gispert, JD, Vilor-Tejedor, N, Alzheimers Dis Neuroimaging Initiat and ALFA study

Publicada: 1 feb 2025 Ahead of Print: 1 ene 2025
Resumen:
INTRODUCTION: Traditional multivariate methods for neuroimaging studies overlook the interdependent relationship between brain features. This study addresses this gap by analyzing relative brain volumetric patterns to capture how Alzheimer's disease (AD) and genetics influence brain structure along the disease continuum. METHODS: This study analyzed data from participants across the AD continuum from the Alzheimer's and Families (ALFA) and Alzheimer's Disease Neuroimaging Initiative (ADNI) studies. Compositional data analysis (CoDA) was exploited to examine relative brain volumetric variations that (1) were linked to different AD stages compared to cognitively unimpaired amyloid-beta-negative (CU A-) individuals and (2) varied by AD genetic risk. RESULTS: Disease stage-specific compositional brain scores were identified, differentiating CU A- individuals from those in more advanced stages. Genetic risk-stratified models revealed a broader genetic landscape affecting brain morphology in AD, beyond the well-known apolipoprotein E epsilon 4 allele. DISCUSSION: CoDA emerges as an alternative multivariate framework to deepen understanding of AD-related structural changes and support targeted interventions for those at higher genetic risk. Highlights Compositional data analysis (CoDA) revealed the relative variation of brain region volumes, captured in compositional brain scores, capable of discerning between cognitively unimpaired amyloid-beta-negative individuals and subjects within other disease-stage groups along the Alzheimer's disease (AD) continuum. CoDA also uncovered the genetic vulnerability of specific brain regions at each stage of the disease along the continuum. CoDA is capable of integrating magnetic resonance imaging data from two different cohorts without stringent requirements for harmonization. This translates as an advantage, compared to traditional methods, and strengthens the reliability of cross-study comparisons by standardizing the data despite different labeling agreements, facilitating collaborative and large-scale research. The algorithm is sensitive to AD-specific effects, as the main compositional brain scores display little overlap with the age-specific compositional brain score. CoDA provides a more accurate analysis of brain imaging data addressing its compositional nature, which can influence the development of targeted approaches, opening new avenues for enhancing brain health.

Filiaciones:
Genius, P:
 Barcelonasseta Brain Res Ctr BBRC, Pasqual Maragall Fdn, C Wellington 30, Barcelona 08005, Spain

 Hosp Mar Res Inst, Barcelona, Spain

 Barcelona Inst Sci & Technol BIST, Ctr Genom Regulat CRG, Barcelona, Spain

 Univ Vic Cent Univ Catalonia UV UCC, Doctoral Sch, PhD programme Bioinformat, Vic, Spain

Calle, ML:
 Univ Vic Cent Univ Catalonia, Fac Sci Technol & Engn, Biosci Dept, Vic, Spain

Rodríguez-Fernández, B:
 Barcelonasseta Brain Res Ctr BBRC, Pasqual Maragall Fdn, C Wellington 30, Barcelona 08005, Spain

 Hosp Mar Res Inst, Barcelona, Spain

 Barcelona Inst Sci & Technol BIST, Ctr Genom Regulat CRG, Barcelona, Spain

Minguillon, C:
 Barcelonasseta Brain Res Ctr BBRC, Pasqual Maragall Fdn, C Wellington 30, Barcelona 08005, Spain

 Hosp Mar Res Inst, Barcelona, Spain

 Inst Salud Carlos III, Ctr Invest Biomed Red Fragil & Envejecimiento Salu, Madrid, Spain

Cacciaglia, R:
 Barcelonasseta Brain Res Ctr BBRC, Pasqual Maragall Fdn, C Wellington 30, Barcelona 08005, Spain

 Hosp Mar Res Inst, Barcelona, Spain

 Inst Salud Carlos III, Ctr Invest Biomed Red Fragil & Envejecimiento Salu, Madrid, Spain

Garrido-Martin, D:
 Univ Barcelona UB, Dept Genet Microbiol & Stat, Barcelona, Spain

:
 Josep Carreras Leukaemia Res Inst IJC, Ctra Can Ruti,Cami Escoles,, Barcelona, Spain

 Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona, Spain

 Univ Barcelona UB, Sch Med & Hlth Sci, Physiol Sci Dept, Barcelona, Spain

 Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain

Navarro, A:
 Barcelonasseta Brain Res Ctr BBRC, Pasqual Maragall Fdn, C Wellington 30, Barcelona 08005, Spain

 Barcelona Inst Sci & Technol BIST, Ctr Genom Regulat CRG, Barcelona, Spain

 Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona, Spain

 Pompeu Fabra Univ, Barcelona, Spain

 Univ Pompeu Fabra, Inst Evolutionary Biol CSIC UPF, Dept Expt & Hlth Sci, Barcelona, Spain

Gispert, JD:
 Barcelonasseta Brain Res Ctr BBRC, Pasqual Maragall Fdn, C Wellington 30, Barcelona 08005, Spain

 Hosp Mar Res Inst, Barcelona, Spain

 Inst Salud Carlos III, Ctr Invest Biomed Red Bioingn Biomat & Nanomed, Madrid, Spain

 Ctr Nacl Invest Cardiovasc CNIC, Madrid, Spain

Vilor-Tejedor, N:
 Barcelonasseta Brain Res Ctr BBRC, Pasqual Maragall Fdn, C Wellington 30, Barcelona 08005, Spain

 Hosp Mar Res Inst, Barcelona, Spain

 Barcelona Inst Sci & Technol BIST, Ctr Genom Regulat CRG, Barcelona, Spain

 Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands
ISSN: 15525260





ALZHEIMERS & DEMENTIA
Editorial
Elsevier BV, 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, Países Bajos
Tipo de documento: Article
Volumen: 21 Número: 2
Páginas:
WOS Id: 001408083900001
ID de PubMed: 39868465
imagen Green Submitted, Green Accepted, hybrid

MÉTRICAS